FDA Inspection 1235997 — Mark Roschewski, M.D.

Mark Roschewski, M.D. — FEI 3018118045

The FDA completed an inspection of Mark Roschewski, M.D. on April 15, 2024 in Bethesda, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 15, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bethesda, MD (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance